首页> 美国卫生研究院文献>Scientific Reports >In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases
【2h】

In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases

机译:针对盘尾丝虫病和相关丝虫病的多表位候选疫苗的计算机设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Onchocerciasis is a parasitic disease with high socio-economic burden particularly in sub-Saharan Africa. The elimination plan for this disease has faced numerous challenges. A multi-epitope prophylactic/therapeutic vaccine targeting the infective L3 and microfilaria stages of the parasite’s life cycle would be invaluable to achieve the current elimination goal. There are several observations that make the possibility of developing a vaccine against this disease likely. For example, despite being exposed to high transmission rates of infection, 1 to 5% of people have no clinical manifestations of the disease and are thus considered as putatively immune individuals. An immuno-informatics approach was applied to design a filarial multi-epitope subunit vaccine peptide consisting of linear B-cell and T-cell epitopes of proteins reported to be potential novel vaccine candidates. Conservation of the selected proteins and predicted epitopes in other parasitic nematode species suggests that the generated chimera could be helpful for cross-protection. The 3D structure was predicted, refined, and validated using bioinformatics tools. Protein-protein docking of the chimeric vaccine peptide with the TLR4 protein predicted efficient binding. Immune simulation predicted significantly high levels of IgG1, T-helper, T-cytotoxic cells, INF-γ, and IL-2. Overall, the constructed recombinant putative peptide demonstrated antigenicity superior to current vaccine candidates.
机译:盘尾丝虫病是一种寄生虫病,具有很高的社会经济负担,尤其是在撒哈拉以南非洲。消除这种疾病的计划面临许多挑战。针对寄生虫生命周期中的感染性L3和微丝aria虫阶段的多表位预防/治疗疫苗对于实现当前的消除目标将是无价的。有几项发现使开发针对这种疾病的疫苗成为可能。例如,尽管暴露于高传染率,但仍有1%到5%的人没有该疾病的临床表现,因此被认为是公认的免疫个体。应用免疫信息学方法设计了丝状多表位亚基疫苗肽,该肽由线性B细胞和T细胞抗原决定簇蛋白组成,据报道它们是潜在的新型疫苗候选物。选择的蛋白质和其他寄生线虫物种中的预测表位的保守性表明,产生的嵌合体可能有助于交叉保护。使用生物信息学工具对3D结构进行了预测,完善和验证。嵌合疫苗肽与TLR4蛋白的蛋白-蛋白对接可预测有效结合。免疫模拟预测IgG1,T辅助细胞,T细胞毒性细胞,INF-γ和IL-2的水平显着升高。总体而言,构建的重组推定肽显示出优于当前候选疫苗的抗原性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号